How Covid-19 could disrupt pharmaceutical supply chains

How Covid-19 could disrupt pharmaceutical supply chains

To start to understand those dynamics, we have to start at the source: The drug manufacturing plants located all over the world. “When you get a bottle of drug, and it has Pfizer’s name on it, it doesn’t mean that Pfizer makes that product,” says Erin Fox, a professor of pharmacotherapy at the University of Utah and expert on drug shortages. The drug company on a prescription bottle is merely the party that is selling you the medication.